Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.
Cognitive Impairment in Multiple Sclerosis: A Review of Neuropsychological Assessments.
Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting.
Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
Activation of Sterol Regulatory Element Binding Factors by Fenofibrate and Gemfibrozil Stimulates Myelination in Zebrafish.
N-Oxides rescue Ru(v) in catalytic Griffith-Ley (TPAP) alcohol oxidations.
Economic Impact of Integrated Care Models for Patients with Chronic Diseases: A Systematic Review.
Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Sulthiame Study Group.
Electrophysiological observations in critically ill Guillain-Barre syndrome.
Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis.
Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.
Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.
CYP4F2 affects phenotypic outcome in adrenoleukodystrophy by modulating the clearance of very long-chain fatty acids.
The 5-HT₆ serotonin receptor antagonist SB-271046 attenuates the development and expression of nicotine-induced locomotor sensitisation in Wistar rats.
Preterm white matter brain injury is prevented by early administration of umbilical cord blood cells.
Pediatric acquired CNS demyelinating syndromes: Features associated with multiple sclerosis.
Evaluation of Patients with Refractory Chronic Inflammatory Demyelinating Polyneuropathy.
Diffusion tensor imaging of occult injury of optic radiation following optic neuritis in multiple sclerosis.
Cognitive dysfunction and behavioral abnormalities in neuromyelitis optica spectrum disorder: report of a case with cortical gray matter involvement and frontotemporal atrophy.
Distinct origins, gene expression and function of microglia and monocyte-derived macrophages in CNS myelin injury and regeneration.
Auditory information processing in rat genotypes with different dopaminergic properties.
Journal Club: Effect of comorbidity on mortality in multiple sclerosis.
[Immune-mediated neuropathies].
Cerebrospinal fluid cytokines in Lyme neuroborreliosis.
Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.
Pages
« first
‹ previous
…
712
713
714
715
716
717
718
719
720
…
next ›
last »